Cencora (0HF3.L)

Healthcare | Medical Distribution
Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$85.9B

Net Income

$560M

Operating Margin

1.2%

Free Cash Flow

$3.2B

Debt / Assets

98.0%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Cencora (0HF3.L).
Income Statement (Quarterly) 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Revenue 85,932,016,000 83,728,554,000 80,663,532,000 75,453,673,000
Cost of Revenue 83,120,346,000 81,125,089,000 78,005,131,000 72,837,849,000
Gross Profit 2,811,670,000 2,603,465,000 2,658,401,000 2,615,824,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 1,795,289,000 1,748,866,000 1,672,881,000 1,600,040,000
Operating Expenses 1,795,289,000 1,748,866,000 1,672,881,000 1,600,040,000
Operating Income 1,016,381,000 854,599,000 985,520,000 1,015,784,000
Interest Expense 72,409,000 109,358,000 116,896,000 132,318,000
Income Before Tax 708,640,000 -187,044,000 896,277,000 928,656,000
Income Tax Expense 142,514,000 146,027,000 206,528,000 211,239,000
Net Income 559,647,000 -339,704,000 687,402,000 717,871,000
Per Share
EPS 2.88 -1.75 3.55 3.70
EPS Diluted 0.00 0.00 0.00 0.00